NCDC DG Chikwe Ihekweazu appointed Assistant DG of WHO
The Director General of the Nigeria Centre for Disease Control (NCDC), Chikwe Ihekweazu, has been appointed as the Assistant Director General of Health Emergency Intelligence at the World Health Organisation (WHO).
Ihekweazu’s appointment – which comes into effect on November 1, 2021 – was disclosed in a letter signed by the WHO Director General, Tedros Ghebreyesus. The letter reads:
“I am pleased to welcome Dr Chikwe Ihekweazu as an Assistant Director-General for Health Emergency Intelligence from November 1, 2021.
“He will lead the work on strengthening pandemic and epidemic intelligence globally, including heading the WHO Hub for Pandemic and Epidemic Intelligence in Berlin.
“Dr Ihekweazu is currently the Director-General of Nigeria Centre for Disease Control. He was trained as an infectious disease epidemiologist, has over 20 years of experience working in senior public health and leadership positions in several National Public Health Institutes, including the South African National Institute for Communicable Diseases, the United Kingdom’s Health Protection Agency, and Germany’s Robert Koch Institute.
“He has led several short-term engagements for WHO, mainly in response to major infectious disease outbreaks around the world.
“Dr Ihekweazu, a Nigerian national, who was born in Germany, is a graduate of the College of Medicine, University of Nigeria and has a Masters in Public Health from the Heinrich-Heine University, Dusseldorf, Germany. In 2003, he was awarded a Fellowship for the European Programme for Intervention Epidemiology Training and subsequently completed his Public Health specialization in the United Kingdom.
“He is widely published in medical peer-reviewed journals,” Ghebreyesus’ statement partly read.
About author
You might also like
Make Health services accessible to all – ‘Save The Children’ tells Nigeria
Nigeria joined the rest of the world yesterday to mark the Universal Health Coverage (UHC) with a call by the Save the Children International, a global charity organization, on governments
BVNL partners South Africa’s Biovac to strengthen vaccine initiative for Africa
Swift from the recent inauguration of the Board of Biovaccines Nigeria Limited (BVNL) last month, the BVNL has “hit the ground running”. The BVNL team paid a working visit to,
Viagra may benefit patients at risk for diabetes, new study shows
The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center Nashville, Tennessee, USA, reported Thursday.
0 Comments
No Comments Yet!
You can be first to comment this post!